AIM ImmunoTech, Inc. (AIM)

1.28 -0.02 (-1.54%) USD  |  NYAM  |  Dec 24, 12:59
1.32 +0.04 (+3.12%) After-Hours: 13:59
More

AIM ImmunoTech CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade